The cardiovascular system undergoes notable structural and haemodynamic changes during the course of pregnancy, such that some call pregnancy nature's stress test. 1 Contrary to previous generally held belief, some recent studies demonstrated a progressive increase in blood pressure (BP) throughout gestation in women who were overweight before pregnancy. 2 In a population-based cohort study, obese and overweight women had a higher BP throughout pregnancy. 3 Substantial ethnic differences exist in the BP levels that are observed during pregnancy and the risk of gestational hypertension. 4 Childbearing was associated with incidence of the metabolic syndrome (MetS) among women with gestational diabetes mellitus (DM) and, after controlling for preconception body mass index (BMI) and MetS components, in primi-and multiparous women without gestational DM as well. 5 Associations between higher parity and prevalence of DM have been mixed, and even an increased risk of DM with nulliparity was reported among Native American women. 6 Multiparity is associated with coronary heart disease (CHD), showing a a J-shaped relationship with higher risk for nulliparous women. 7, 8 Decreases in serum creatinine and uric acid values have been attributed to rises in glomerular filtration rates by the end of the first trimester. 9 Higher baseline levels of a measure of aortic stiffness have been observed in multiparous compared with nulliparous women. 1 Both multiparity and nulliparity have been associated with higher insulin levels many years after childbearing. 10 Viewed from the perspective of correlates of lipoprotein(a) (Lp(a)), 11 gestation may reflect underlying 'reduced' serum Lp(a) assays and autoimmune activation.
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Influence of lactation
A prospective study on a relatively small sample examined the relationship between lactation and changes in maternal metabolic risk factors and found a tendency towards improved serum high-density lipoprotein cholesterol and fasting insulin, 12 changes that are potentially consistent with underlying rises in Lp(a) levels. 11 Longer duration of lactation was associated with a lower incidence of the MetS years after delivery and after weaning among women with non-gestational DM, as well as with gestational DM pregnancies. Lactation may ameliorate the increased risk of the MetS that is associated with higher parity. 5 Data from the Coronary Artery Risk Development in Young Adults (CARDIA) study provided evidence that lactation may have lasting favourable effects on the risk of the MetS among women, regardless of a history of gestational DM. 13 However, this protection seemed to be absent in overweight women and black women without gestational DM, suggesting a possible interaction with adiposity, given the generally inverse association between BMI and Lp(a) and the existence of two-fold higher Lp(a) levels in black compared with white women. 11 In a cohort of 177,749 Korean premenopausal women, the risk of the development of hypertension was significantly reduced by lactation. The coexistence of obesity and no lactation interacted significantly. 14 In the large Nurses' Health Study II, never or curtailed lactation was associated with an increased risk of maternal hypertension, compared with !6 months of exclusive lactation per child. 15 In a large study of parous Chinese women against incident type 2 DM breastfeeding appeared to protect modestly (by 12%) and at borderline significance (p ¼ 0.08), compared to women who had never breastfed. Cumulative lifetime breastfeeding exhibited a trend for reduced DM risk (p ¼ 0.01). 16 In the two cohorts of the Nurses' Health Study, an increasing duration of lactation was associated with a modestly Department of Cardiology, Cerrahpas¸a Medical Faculty, Istanbul University, Turkey reduced risk of type 2 DM. However, a non-linearity of effect was observed, so that fewer than 6 months of cumulative lactation proved to be of no benefit, and women with gestational DM did not seem to be protected against DM by lactation. 17 Evidence of non-linearity for incident DM by total lifetime duration and by duration of breastfeeding per child was also reported in a meta-analysis comprising six studies, in which a significant inverse association was found between breastfeeding and maternal risk of DM. 18 In the EPIC-Potsdam study of 226 pregnant women, incident DM risk was not significantly related to cumulative duration of breastfeeding, except for a duration of 6 months or more, which tended to be protective. 19 This protective effect seemed to be reflected by a more favourable metabolic profile (plasma atherogenic index and adiponectin). Non-linearity of a biomarker in association with an outcome is often related to plasma proteins sustaining epitope damage due to oxidative stress, which has the capacity to impact on the risk of cardiometabolic disease. 20 It is notable that the Helsinki Birth Cohort study of 967 women showed a significant inverse association between birth length and subsequent development of CHD, 21 suggesting that the interplay of oxidised Lp(a) and a proinflammatory state with both body height and impact on incident CHD.
In the current issue of this journal, the paper by Peters and associates 22 presents a case-cohort study that tracked 14,917 women from ten European countries who had no known history of CHD or stroke at baseline and who provided reproductive histories. Incidence rates of fatal and nonfatal CHD over 11 years of follow-up with regards to parity, number of children, breastfeeding and duration of breastfeeding were analysed. Age at study entry was 53 AE 9 years. The authors found that, overall, parity independently increased the incidence rate by 19% compared with nulliparous women, and that the number of children tended to increase these rates; breastfeeding, on the other hand, diminished them (hazard ratio: 0.71; 95% confidence interval: 0.52-0.98). Even fewer than 3 months of lifetime breastfeeding or less than 1 month of breastfeeding per child were associated with a significantly reduced future CHD risk, which displayed further modest reduction with more prolonged breastfeeding. Peters et al. imply that, if these relationships are causal, the promotion of prolonged breastfeeding in parous women may confer long-term cardiovascular benefits.
A working hypothesis on the mechanisms of the effects of lactation
Despite there having been numerous attempts to explain the mechanisms underlying the beneficial effects of lactation on future cardiometabolic diseases, investigators are unanimous that such causal mechanisms remain undiscovered. The crucial aspect of this association is its manifestation many years after breastfeeding. Gestation, which is a physiological process, is fraught with complications in the short term, which include the development of hypertension, pre-eclampsia, the MetS and type 2 DM, indicating that enhanced systemic inflammation and oxidative stress may be prominent in some women during gestation. In the absence of an appropriate duration of breastfeeding, multiparity contributes to an elevated long-term risk of cardiometabolic disorders. The following is proposed as a working hypothesis.
A process of a proinflammatory state may prevail during pregnancy, with increased serum macrophage migration inhibitory factor (MIF) inducing underlying epitope damage in inflammatory proteins such as circulating Lp(a), which is associated with the activation of autoimmunity that involves protective plasma proteins such as high-density lipoprotein, apolipoprotein A-I, adiponectin and sex hormone-binding globulin. Such a constellation has been documented among a Turkish adult population as being associated with an elevated future risk of DM, 23 prehypertension 24 and CHD, 25 and moderately reduced levels of Lp(a) are associated with the MetS in humans. Korean women with the MetS were reported to have elevated MIF levels. 26 A U-shaped relationship between the duration of lactation and hypertension in Korean premenopausal women was linked to an interaction between obesity and a lack of lactation. 14 Lactation may improve insulin sensitivity and glucose tolerance, 17 thus causing moderate short-term improvements in oxidative stress and associated autoimmune process, but the maternal substrate is affected by the subsequent existence of proinflammatory processes, such as obesity.
Italian investigators examining the association between maternal MIF concentrations and gestational pre-eclampsia, who had previously found elevated circulating MIF levels compared to pregnant women without pre-eclampsia, 27 later reported the existence of lower MIF concentrations in maternal serum before the onset of pre-eclampsia in a prospective analysis of 127 pregnant women. 28 This supports the precedence of autoimmune activation in pre-eclampsia, during which circulating MIF levels presumably increase. This is also analogous to the inverse association between circulating Lp(a) and the risk of type 2 DM 23 that was observed in the large prospective Women's Health Study. 29 Thus, the modest improvement in the long-term risk of cardiometabolic disorders resulting from an appropriate duration of lactation may constitute only a transient mediator of regressed oxidative stress in pregnant women, and may be a bystander marker of long-term improvement in the underlying pathogenic mechanism (Figure 1 ). This process is determined by genetics and race and is driven by excess adiposity, MIF and Lp(a) levels and whether and to the extent to which autoimmune activation is involved. 24 In order to better elucidate the degree of the role of this maternal substrate, there is a need for future research directed at the analysis of the elements of oxidative stress during gestation, postpartum and lactation, as well as the association of these findings with subsequent cardiometabolic risk, in different ethnicities/races and population segments that are prone to impaired glucose tolerance or the MetS.
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